2018
DOI: 10.1016/j.clineuro.2018.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Motor neuron disease in patients with HIV infection: Report of two cases and brief review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…Combination antiretroviral medications may slow advancement and potentially reverse symptomology of an ALS-like syndrome in HIV-infected individuals [4, 5]. One study observed motor neuron disease is increasingly less progressive and more responsive to HAART as the time from HIV infection to ALS onset increases [9]. Furthermore, it has been proposed that the HIV virus could mutate to selectively infect motor neurons, offering an explanation for the efficacy of HAART in slowing or reversing symptomology, although no direct evidence supports the theory [7].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…Combination antiretroviral medications may slow advancement and potentially reverse symptomology of an ALS-like syndrome in HIV-infected individuals [4, 5]. One study observed motor neuron disease is increasingly less progressive and more responsive to HAART as the time from HIV infection to ALS onset increases [9]. Furthermore, it has been proposed that the HIV virus could mutate to selectively infect motor neurons, offering an explanation for the efficacy of HAART in slowing or reversing symptomology, although no direct evidence supports the theory [7].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…This case report present a course of motor-neuron disease in a patient with type I HIV as well as other cases in the literature (Casado et al1997, Galassi et al 1998, Sinha et al2004, Lorenzoni et al 2018. Due the time of evolution and the no improvement of the symptoms with the new antiretroviral treatment we face a case of Amyotrophic Lateral Sclerosis with a very slow progression (Casado et al 1997).…”
Section: Discussionmentioning
confidence: 70%
“…The eatiology has been described as genetic or sporadic, having a high contribution for its pathogenic course. In the last decades, there were some cases of sporadic ALS in patients with infectious disease such like HIV-1 (Galassi et al 1998, Sinha et al 2004, Lorenzoni et al 2018, which help configurating a hypothesis of an infectious aetiology in this cases, with an ALS-like syndrome with predilection for the spinal cord anterior horn cells (Levin SN & Lyons JI, 2018) and, when treated with an specific antiretroviral, has a complete remission (Sinha et al 2004). In 2016 Owens and colleagues identified the activation of HERV-k, an endogenous retrovirus, in this type of patients, with an increase plasma level that received antiretroviral therapy with a good penetrance in the central nervous system and had reversal of symptoms within 6 months of onset of neurologic symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…HIV vacuolar myelopathy was considered, but this usually involves the sensory tracts, which were intact in our patient [7] . HIV can also cause motor neuron disease that can be predominantly upper motor neuron, but this is not very common [8] . Other causes of progressive spastic paraparesis include nutritional deficiencies (B12, copper, vitamin E, folate), toxicities (nitrous oxide, others), or hereditary causes (eg, adult onset adrenomyeloneuropathy, hereditary spastic paraplegia, etc.…”
Section: Discussionmentioning
confidence: 99%